# DESCRIPTION

## FIELD

- define scope of disclosure

## BACKGROUND

- motivate antibiotic therapy
- describe antibiotic resistance
- introduce bacteriocins
- highlight advantages of bacteriocins
- discuss synergistic effects
- mention food industry applications
- describe class IIa bacteriocins
- highlight challenges of bacteriocin synthesis
- summarize prior art

## SUMMARY

- relate to gram-positive class II bacteriocins
- relate to novel antibacterial peptides
- relate to linear synthesis of gram-positive class II bacteriocins
- relate to solid phase peptide synthesis
- relate to pediocin PA-1 synthesis
- relate to bactofencin A synthesis
- relate to stepwise addition of amino acids
- relate to pseudoproline positioning and reopening
- relate to cleavage of bacteriocin from solid support
- relate to in situ disulfide bond formation
- relate to treating linear bacteriocin with acid
- relate to oxidative coupling of thiol containing amino acid residues
- relate to in situ disulfide bond formation by contacting with medium
- relate to composition comprising bacteriocin and pharmacologically acceptable carrier
- relate to synthetic bacteriocin obtained by linear solid phase peptide synthesis
- relate to method for prevention and/or treatment of bacterial related infections
- relate to administering effective amount of bacteriocin
- relate to method of preserving food item
- relate to applying effective amount of bacteriocin to food item
- relate to bactericidal food preservation composition
- relate to coating food product for preservation
- relate to item comprising surface with antimicrobial effective amount of bacteriocin
- relate to medical device with antimicrobial effective amount of bacteriocin
- relate to medical instrument with antimicrobial effective amount of bacteriocin
- relate to medical implement with antimicrobial effective amount of bacteriocin
- relate to variants of pediocin PA-1
- relate to variants of bactofencin A
- relate to linear synthesis of pediocin PA-1
- relate to linear synthesis of bactofencin A
- relate to linear synthesis of variants of pediocin PA-1
- relate to linear synthesis of variants of bactofencin A
- relate to composition comprising variants of pediocin PA-1
- relate to composition comprising variants of bactofencin A
- relate to method of preserving food item with variants of pediocin PA-1 or bactofencin A
- introduce bacteriocin-based items
- specify bacteriocin types
- describe kit embodiments
- detail bacteriocin applicators
- introduce preservative embodiments
- specify preservative bacteriocins
- describe food packaging embodiments
- detail food packaging bacteriocins
- introduce synthetic bacteriocins
- specify synthetic bacteriocin types
- describe synthetic bacteriocin synthesis
- detail disulfide bond formation
- introduce gram-positive class II bacteriocins
- specify gram-positive class II bacteriocin types
- describe gram-positive class II bacteriocin purity
- detail gram-positive class II bacteriocin synthesis
- introduce gram-positive class II bacteriocin variants
- specify gram-positive class II bacteriocin variant types
- describe gram-positive class II bacteriocin variant purity
- detail gram-positive class II bacteriocin variant synthesis
- introduce disulfide bond generation
- conclude bacteriocin embodiments
- relate to solid phase peptide synthesis
- relate to linear gram-positive class II bacteriocins
- relate to linear gram-positive class IIa bacteriocins
- relate to linear gram-positive class IIb bacteriocins
- relate to linear gram-positive class IIc bacteriocins
- relate to linear gram-positive class IId bacteriocins
- relate to disulfide bond formation
- relate to in situ disulfide bond formation
- relate to novel antimicrobial agents
- relate to use of novel antimicrobial agents
- relate to embodiments 1 to 73
- describe process for linear synthesis of bacteriocin
- describe process for linear synthesis of gram-positive class II bacteriocin
- describe disulfide bond formation
- describe in situ disulfide bond formation
- describe solid support
- describe resin linker
- describe acid treatment
- describe gram-positive class II bacteriocin variants
- describe amino acid substitutions
- describe process for linear synthesis of gram-positive class II bacteriocin with in situ disulfide bond formation
- describe composition comprising bacteriocin
- describe method for prevention and/or treatment of bacterial related infections
- describe method of preserving a food item
- describe bactericidal food preservation composition
- describe item with antimicrobial surface
- describe kit comprising bacteriocins
- describe preservative
- describe food packaging
- describe specific bacteriocins
- describe synthetic gram-positive class II bacteriocin
- describe pediocin PA-1 or variants
- describe bactofencin A or variants
- describe embodiments 1 to 73
- describe embodiments 1 to 73
- describe embodiments 1 to 73
- describe embodiments 1 to 73
- describe embodiments 1 to 73
- describe embodiments 1 to 73
- describe embodiments 1 to 73
- describe embodiments 1 to 73
- describe embodiments 1 to 73
- describe embodiments 1 to 73
- describe embodiments 1 to 73
- describe embodiments 1 to 73

## DETAILED DESCRIPTION

### Glossary

- define terms used in the disclosure
- clarify meaning of "a" and "an"
- explain "comprising" and its derivatives
- define "consisting" and its derivatives
- explain "consisting essentially of"
- define "about", "substantially", and "approximately"
- define "suitable"
- explain "proceed to a sufficient extent"
- define "analogue"
- define "chemical modification"
- define "amino acid"
- explain L-amino acids and D-amino acids
- define "resin linker"
- explain conservative changes to amino acid sequences
- define "sequence identity"
- explain linear synthesis of gram-positive class IIa, IIb, IIc or IId bacteriocins
- describe synthetic gram-positive class IIa, IIb, IIc or IId bacteriocins
- explain variants of synthetic bacteriocins
- describe length of synthetic bacteriocins
- relate to process for linear synthesis of gram-positive class IIa bacteriocins
- describe linear synthesis of pediocin PA-1
- explain use of linear solid phase peptide synthesis
- describe synthesis of bactofencin A
- explain Fmoc/t-Bu strategy on a HMPB-ChemMatrix solid support
- obviate need for disulfide formation prior to use
- allow for ready substitution of amino acids
- relate to linear solid phase peptide synthesis of pediocin PA-1 and variants
- describe conditions for process/method steps
- explain need to protect certain side chains of amino acids
- describe procedures for protecting functional groups
- reference external sources for protective groups in organic synthesis
- introduce pediocin PA-1 synthesis
- select solid support for synthesis
- describe initial attempt at synthesis
- identify problematic amino acid couplings
- incorporate pseudoprolines to address couplings
- describe peptide cleavage from resin
- describe TFA cocktail composition
- describe side-chain alkylated peptides impurity
- describe treatment to avoid alkylated adducts
- describe purity of synthetic linear gram-positive class II bacteriocins
- describe formation of selective disulfide linkages
- describe oxidation of Met31 residue
- describe reduction of Met31 residue
- describe purification of pediocin PA-1 3c
- describe confirmation of pediocin PA-1 3c presence
- describe synthesis of pediocin PA-1 3a and 3b
- describe antimicrobial activity of pediocin PA-1 3a-c
- describe synthesis of pediocin PA-1 4
- describe disulfide bond formation of pediocin PA-1 4
- describe synthesis of pediocin PA-1 6
- describe antimicrobial activity of pediocin PA-1 1, 2a, 3a-c, 4, and 6
- describe radial diffusion assays
- describe antibacterial activity of pediocin PA-1 3c
- describe antibacterial activity of pediocin PA-1 3a and 3b
- describe antibacterial activity of pediocin PA-1 1 and 4
- describe antibacterial activity of pediocin PA-1 6
- describe bactofencin A linear analogs 7 and 8
- describe antimicrobial activity of bactofencin A linear analogs 7 and 8
- describe in situ disulfide bond formation in biological matrix
- describe circular dichroism experiments
- describe 1H NMR spectroscopy studies
- describe lowest relative energy structure of pediocin PA-1 analog 5
- describe process for linear synthesis of gram-positive class IId bacteriocins
- describe linear solid phase peptide synthesis of bactofencin A
- describe protecting functional groups on amino acid side chains
- describe Fmoc-NÎ±/t-Bu solid phase peptide synthesis
- describe leucine for methionine substitution
- describe amidated C-terminal and acetylated N-terminal
- describe substitution of HMPB-ChemMatrix for 2-TCP resin
- describe cysteine replacement and alanine substitutions

## EXPERIMENTAL

- provide examples of linear synthesis of gram-positive class II bacteriocins and compositions and uses thereof

### Example 1: Materials

- list materials used in peptide synthesis

### Example 2: Analytical Analyses

- describe LC/MS analyses
- describe HRMS and MALDI-TOF mass spectrometry

### Example 3: Peptide Synthesis

- describe peptide synthesis using Fmoc solid-phase synthesis
- describe preparation of HMPB-ChemMatrix resin
- describe C-terminal amino acid attachment
- describe peptide elongation and cleavage

### Example 4: Disulfide Bond Formation

- describe disulfide bond formation using NCS

### Example 5: Selective Methionine Reduction

- describe selective methionine sulfoxide reduction

### Example 6: Antimicrobial Assays

- describe radial diffusion assays
- describe MIC determination
- describe skim milk experiment
- describe antibacterial activity assessment
- describe MIC values determination

### Example 7: Circular Dichroism (CD)

- describe CD measurements in aqueous TFE solutions
- describe CD measurements in phospholipid vesicles

### Example 8: NMR Spectroscopy

- describe NMR spectroscopy experiments

### Example 9: In Situ Disulfide Bond Formation

- describe incorrect disulfide bond pairings
- describe in situ disulfide bond formation hypothesis
- describe importance of disulfide bonds for pediocin PA-1 activity

